ANDCEF

This brand name is authorized in Nigeria.

Active ingredients

The drug ANDCEF contains one active pharmaceutical ingredient (API):

1	Ceftriaxone UNII 023Z5BR09K - CEFTRIAXONE SODIUM
	Ceftriaxone is an antibacterial for systemic use, a third-generation cephalosporin. It inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs) leading to bacterial cell lysis and death.
	Read more about Ceftriaxone

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-9120	Injection	ANDCEF CEFTRIAXONE INJECTION 1G INJ 1 g 1 X 1 VIAL + STERILE WATER FOR INJECTION USP 10ML	ANDCEF CEFTRIAXONE INJECTION 1G ANDCEF STERILE CEFTRIAXONE SODIUM USP EQ. TO CEFTRIAXONE ANHYDROUS 1GM POM INJECTION 1 X 1 VIAL + STERILE WATER FOR INJECTION USP 10ML ANTIBIOTICS EUROMED LTD 34/36, ASSOCIATION AVENUE, ILUPEJU, LAGOS STATE KILITCH DRUGS (INDIA) LTD C-301/2, TTC INDL, AREA, MIDC, PAWANE, NAVI MUMBAI-400 705, INDIA GMP- SATIS; LR- SATIS; FEES- PAID; NP: NA 16/10/2017 R R R B4-9120	30/01/2020

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD04	Ceftriaxone	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-9120